ArticleQuantitative imaging in medicine and surgery2025
Reduced pulmonary vascular bed volume in cryptogenic stroke patients with patent foramen ovale: a myocardial contrast echocardiography study.
Article in Quantitative imaging in medicine and surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Pulmonary vascular bed volume (PVBV) in cryptogenic stroke patients with patent foramen ovale (PFO) has not been well characterized. This study examined PVBV in cryptogenic stroke patients with suspected PFO. Methods: A total of 469 patients underwent agitated saline contrast transthoracic echocardiography (TTE) and transesophageal echocardiography (TEE) between January 2021 and December 2024. PVBV was quantified by myocardial contrast echocardiography (MCE). Results: Of the included patients, 423 were diagnosed with PFO, and 46 served as controls. The PFO group demonstrated elevated pulmonary vascular resistance (PVR) and reduced right ventricular systolic function (all P<0.05), with significantly reduced PVBV compared to controls [242.89 (202.91-465.05) Conclusions: PVBV is reduced in cryptogenic stroke patients with PFO, and right-to-left shunt level, BSA, and gender were the factors associated with PVBV. Addressing these gaps could enhance the understanding of cardiopulmonary interactions in PFO.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.